Legal Status Overview
Gray AreaNorth Carolina has no state statute, administrative code section, or Board of Pharmacy rule that names peptides or "research chemicals" as a distinct legal category, so the state simply defers to federal drug law and general pharmacy/compounding regulation. Federally, peptides such as BPC-157 and TB-500 have not been approved by the FDA for human use and are not yet on the FDA's list of bulk substances that outsourcing facilities and compounding pharmacies may legally use, though an FDA advisory committee recently recommended adding several of them to that list. Prescription peptide drugs that are FDA-approved (like semaglutide/tirzepatide for diabetes or weight loss, or prescription human growth hormone) remain legal in North Carolina only when dispensed under a valid prescription through a licensed pharmacy.
Key Points
- North Carolina has no peptide-specific or "research chemical"-specific statute or Board of Pharmacy rule; searches of North Carolina law and Board of Pharmacy materials found no state provision naming peptides, BPC-157, TB-500, or research-use-only compounds as a distinct legal category. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- The FDA's Pharmacy Compounding Advisory Committee voted in 2026 to recommend that the FDA add BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax to the federal 503A Bulks List, the list that governs which bulk peptide substances a compounding pharmacy anywhere in the U.S., including North Carolina, may legally use. [1]
- As of the FDA's 2026 advisory committee review, BPC-157 has no FDA approval for any human use, meaning compounding or selling it for human administration falls outside FDA-recognized legitimate use even though no North Carolina-specific ban exists. [5]
- An FDA advisory committee's vote to recommend BPC-157 for the compounding bulks list was described by national reporting as bringing the peptide "one step closer to being legally available to Americans with a prescription," implying it is not currently legally available by prescription anywhere in the U.S., including North Carolina. [3]
- Peptide vendors actively market directly to North Carolina customers, labeling products as "Research Use Only (RUO)" intended for laboratory investigation rather than human or animal administration, which is the common workaround used because no North Carolina statute directly restricts RUO peptide sales. [6]
- No North Carolina-specific rule on personal importation or travel with peptides was found; whether bringing peptides into North Carolina for personal use is lawful depends on federal FDA/customs rules on unapproved drugs rather than any distinct North Carolina provision. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- No North Carolina-specific enforcement actions, Board of Pharmacy bulletins, or attorney general guidance concerning peptides, BPC-157, or compounded GLP-1 products were located in this research, suggesting enforcement in North Carolina currently relies on general federal FDA/DEA authority rather than a distinct state enforcement program. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in North Carolina
| BPC-157 | BPC-157 has no FDA-approved medical use and is not currently on the federal 503A compounding bulks list, so in North Carolina it can only be lawfully obtained as an unapproved "research use only" product rather than as a prescribed medicine, pending the outcome of the FDA's 2026 advisory committee recommendation to add it to that list. [1] |
|---|---|
| Semaglutide/Tirzepatide (GLP-1 class) | No North Carolina-specific rule on compounded semaglutide or tirzepatide was found in this research, so their legal status in North Carolina follows the general federal rule that brand-name FDA-approved versions are prescription-only, while compounded versions are subject to federal 503A/503B shortage-related restrictions rather than any distinct state peptide law. |
| TB-500 | TB-500 has no FDA approval for human use and, like BPC-157, was recently nominated to the FDA's 503A bulk drug substances list rather than being currently approved, meaning in North Carolina it remains an unapproved research peptide rather than a lawful prescription product. [1] |
| Human Growth Hormone (HGH/somatropin) | No North Carolina-specific statute or Board of Pharmacy rule on HGH was identified in this research, so its status in North Carolina rests on general federal law treating FDA-approved somatropin as a prescription-only drug, without a distinct state-level rule found to confirm additional restrictions. |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in North Carolina without a prescription?
There is no North Carolina statute that separately regulates peptide sales, so vendors are able to sell unapproved peptides like BPC-157 to North Carolina customers labeled "research use only," a labeling practice that vendors use because these products lack FDA approval for human use rather than because a North Carolina prescription exemption exists. [6]
Is BPC-157 legal in North Carolina?
BPC-157 is not FDA-approved for human use and is not currently on the federal list of substances pharmacies may legally compound, so in North Carolina it exists in a regulatory gray area as an unapproved research chemical rather than as a legal prescription medicine, even though the FDA's advisory committee recently recommended a pathway that could change this. [1]
Can I get compounded semaglutide or tirzepatide through telehealth in North Carolina?
This research did not find a North Carolina-specific telehealth or Board of Pharmacy rule addressing compounded GLP-1 prescribing, so the answer depends on general federal compounding law (503A/503B) and standard North Carolina telehealth prescribing requirements rather than any peptide-specific state rule.
What are the penalties for selling or possessing unapproved peptides in North Carolina?
No North Carolina-specific penalty provision or reported enforcement action for peptide or research-chemical sales was found in this research, so any enforcement in North Carolina would most likely proceed under general federal FDA misbranding/unapproved-drug authority rather than a distinct state peptide penalty.
Is human growth hormone (HGH) legal to buy in North Carolina?
No North Carolina-specific HGH statute was identified in this research, so HGH's legality in North Carolina follows the general federal rule that FDA-approved somatropin is a prescription-only drug, without confirmation of any additional state-level restriction beyond that federal baseline.